Harold K. K. Lee

Oral arsenic trioxide–based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study

Wing‐Yan Au, Cyrus R. Kumana, Harold K. K. Lee et al. · Blood · 2011 · 113 citations

Medicine, Hematology, Oncology +6

Long‐term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide‐based reinduction and maintenance regimens: A 15‐year prospective study

Harinder Gill, Rita Yim, Harold K. K. Lee et al. · Cancer · 2018 · 79 citations · Full text

Medicine, Hematology, Oncology +10

Oral arsenic trioxide incorporation into frontline treatment with all‐trans retinoic acid and chemotherapy in newly diagnosed acute promyelocytic leukemia: A 5‐year prospective study

Harinder Gill, Cyrus R. Kumana, Rita Yim et al. · Cancer · 2019 · 55 citations · Full text

Medicine, Hematology, Oncology +15

Sorafenib and omacetaxine mepesuccinate as a safe and effective treatment for acute myeloid leukemia carrying internal tandem duplication of Fms‐like tyrosine kinase 3

Chunxiao Zhang, Stephen S.Y. Lam, Garret M. K. Leung et al. · Cancer · 2019 · 35 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Distinct mutation spectrum, clinical outcome and therapeutic responses of typical complex/monosomy karyotype acute myeloid leukemia carrying <i>TP53</i> mutations

Garret M. K. Leung, Chunxiao Zhang, Nelson K.L. Ng et al. · American Journal of Hematology · 2019 · 34 citations · Full text

Medicine, Hematology, Oncology +17